|
Video: What is a Stock Split?
|
|
POINT Biopharma Global is a radiopharmaceutical company focusing on the clinical development and commercialization of radioligands for cancer treatment. Co.'s product candidates include: PNT2002, which is a prostate-specific membrane antigen (PSMA) targeted radioligand for the treatment of metastatic castration-resistant prostate cancer; PNT2004, which is a fibroblast activation protein-a targeting program being developed for use in several tumor types; PNT2003, which is a somatostatin-targeted radioligand in development for the treatment of neuroendocrine tumors; and PNT2001, which is a PSMA targeting ligand family that utilizes linker technology that promotes increased tumor accumulation. According to our PNT stock split history records, PNT has had 0 splits. | |
|
PNT (PNT) has 0 splits in our PNT stock split history database.
Looking at the PNT stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PNT shares, starting with a $10,000 purchase of PNT, presented on a split-history-adjusted basis factoring in the complete PNT stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/09/2020 |
|
End date: |
12/27/2023 |
|
Start price/share: |
$13.74 |
|
End price/share: |
$12.50 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-9.06% |
|
Average Annual Total Return: |
-2.70% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,094.30 |
|
Years: |
3.47 |
|
|
|
|
|